ARTICLE | Company News
Questcor, Shire Pharmaceuticals Group plc deal
November 5, 2001 8:00 AM UTC
SHP declined its option under a 1998 deal to acquire exclusive North American marketing rights for QSC's Emitasol metoclopramide to treat nausea and vomiting associated with chemotherapy. ...